How much funding has Rejoni raised?

Rejoni has raised $40.0M in total funding, most recently a Series B round.

Who are Rejoni's investors?

Rejoni's investors include Catalyst Health Ventures, Ascension Ventures, Delos Capital, Sparta Group, Ascension Health, ClavystBio.

Where is Rejoni headquartered?

Rejoni is headquartered in Bedford, Massachusetts, United States.

What industry is Rejoni in?

Rejoni operates in Healthcare, Medical Devices.

Rejoni

We are elevating uterine health.

Bedford, United States · Founded 2020 · $40.0M raised

Healthcare

Medical Devices

Headquarters: Bedford, Massachusetts
Employees: 11–50
Founded: 2020
Business Model: B2B

Website: rejoni.com
Total Funding: $40.0M
Last Round: $25.0M Series BDec 2022
Rounds: 2

About

Rejoni, Inc. is a privately held women's health company based in Bedford, MA, focused on developing and commercializing therapeutic products in gynecology using its proprietary biomaterials platform. Founded in 2020 by serial entrepreneur Amar Sawhney, PhD, the company is dedicated to protecting, preserving, and healing the uterus. Its lead product, the Juveena Hydrogel System, is a minimally invasive gynecologic device currently under FDA PMA review. Rejoni is committed to helping women achieve better health outcomes through innovative biomaterial-based solutions that address long-underserved uterine health challenges.

Summary

Rejoni is a Healthcare company based in Bedford, United States, founded in 2020. It has raised $40.0M in total across 2 rounds, most recently a $25.0M Series B round in Dec 2022. Investors include Catalyst Health Ventures, Ascension Ventures and Delos Capital.